About Krueppel-like factor 4
Krueppel-like factor 4 (KLF4) is a protein
from Homo sapiens identified by UniProt accession
O43474, 513 residues long.
MolForge cross-references it against 0 known binders and
672 disease associations.
Target properties
| Protein name | Krueppel-like factor 4 |
| UniProt accession | O43474 |
| Gene | KLF4 |
| Organism | Homo sapiens |
| Length | 513 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (672)
Diseases linked to this target (Open Targets).
- breast carcinoma · score 0.50
- neurodegenerative disease · score 0.48
- prostate carcinoma · score 0.39
- Secretory Meningioma · score 0.37
- Chordoid Meningioma · score 0.37
- Meningothelial Meningioma · score 0.37
- Transitional Meningioma · score 0.37
- Atypical Meningioma · score 0.37
- Endometrial Endometrioid Adenocarcinoma · score 0.37
- meningioma · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43474-F1 | alphafold | PREDICTED | 48.94 | — |
Amino-acid sequence (513 residues)
MRQPPGESDM AVSDALLPSF STFASGPAGR EKTLRQAGAP NNRWREELSH MKRLPPVLPG RPYDLAAATV ATDLESGGAG AACGGSNLAP LPRRETEEFN DLLDLDFILS NSLTHPPESV AATVSSSASA SSSSSPSSSG PASAPSTCSF TYPIRAGNDP GVAPGGTGGG LLYGRESAPP PTAPFNLADI NDVSPSGGFV AELLRPELDP VYIPPQQPQP PGGGLMGKFV LKASLSAPGS EYGSPSVISV SKGSPDGSHP VVVAPYNGGP PRTCPKIKQE AVSSCTHLGA GPPLSNGHRP AAHDFPLGRQ LPSRTTPTLG LEEVLSSRDC HPALPLPPGF HPHPGPNYPS FLPDQMQPQV PPLHYQGQSR GFVARAGEPC VCWPHFGTHG MMLTPPSSPL ELMPPGSCMP EEPKPKRGRR SWPRKRTATH TCDYAGCGKT YTKSSHLKAH LRTHTGEKPY HCDWDGCGWK FARSDELTRH YRKHTGHRPF QCQKCDRAFS RSDHLALHMK RHF
Explore Krueppel-like factor 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets